We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade

This study has been withdrawn prior to enrollment.
(Funding expired; no subjects enrolled as this was a retrospective chart review)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00233467
First Posted: October 5, 2005
Last Update Posted: September 14, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Lori Davis, MD, Tuscaloosa Research & Education Advancement Corporation
  Purpose
The main purpose is to show the percentage of patients taking antipsychotics with PTSD by looking at approximately ten year's worth of data from 1994 through 2004. We will also determine the type and dose of antipsychotics the patients received, and to determine how many of those patients had psychotic versus nonpsychotic symptoms. We will be obtaining this data from the VISN 7 Corporate Data Warehouse. We hypothesize that there has been an overall increase in antipsychotic use in patient's with PTSD over the last 10 years.

Condition
PTSD Posttraumatic Stress Disorder

Study Type: Observational
Study Design: Observational Model: Other
Time Perspective: Retrospective
Official Title: Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade

Resource links provided by NLM:


Further study details as provided by Lori Davis, MD, Tuscaloosa Research & Education Advancement Corporation:

Enrollment: 0
Actual Study Start Date: September 1, 2005
Study Completion Date: September 30, 2005
Primary Completion Date: September 30, 2005 (Final data collection date for primary outcome measure)
Detailed Description:

This study is a retrospective chart review of patients, at the Tuscaloosa VA Medical Center, who were, treated with antipsychotics as monotherapy or adjunctive therapy.

The data will be retrieved from a computerized list of patients treated at the TVAMC for PTSD from 1994-2004 Charts will be reviewed by looking at approximately ten year's worth of data. Charts will then be examined to determine what type of antipsychotics patients were prescribed, the dose and duration of the antipsychotics, and the presence or absence of documented psychotic symptoms.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Chart review of Veterans on antipsychotics
Criteria

Inclusion Criteria:

  1. Have a diagnosis of PTSD (309.81)
  2. Male or female patients at least 19 years of age

Exclusion Criteria:

• None

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00233467


Locations
United States, Alabama
Tuscaloosa VA Medical Center
Tuscaloosa, Alabama, United States, 35404
Sponsors and Collaborators
Tuscaloosa Research & Education Advancement Corporation
Investigators
Principal Investigator: Rebecca Seamans, PharmD Tuscaloosa VA Medical Center
  More Information

Publications:
Responsible Party: Lori Davis, MD, ACSO for Research, Tuscaloosa Research & Education Advancement Corporation
ClinicalTrials.gov Identifier: NCT00233467     History of Changes
Other Study ID Numbers: TREAC Retro PTSD
First Submitted: October 3, 2005
First Posted: October 5, 2005
Last Update Posted: September 14, 2017
Last Verified: September 2017

Keywords provided by Lori Davis, MD, Tuscaloosa Research & Education Advancement Corporation:
antipsychotics
PTSD
posttraumatic stress disorder

Additional relevant MeSH terms:
Disease
Stress Disorders, Traumatic
Stress Disorders, Post-Traumatic
Pathologic Processes
Trauma and Stressor Related Disorders
Mental Disorders
Antipsychotic Agents
Tranquilizing Agents
Central Nervous System Depressants
Physiological Effects of Drugs
Psychotropic Drugs